Advanced search
Start date
Betweenand


Polimorfismos no gene da Cu, Zn-superóxido dismutase, estado nutricional relativo ao Zn e estresse oxidativo em pacientes com câncer da cavidade oral e orofaringe

Full text
Author(s):
Suzana Bressan
Total Authors: 1
Document type: Master's Dissertation
Press: São Paulo.
Institution: Universidade de São Paulo (USP). Conjunto das Químicas (IQ e FCF) (CQ/DBDCQ)
Defense date:
Examining board members:
Thomas Prates Ong; Marcos Brasilino de Carvalho; Marcelo Macedo Rogero
Advisor: Thomas Prates Ong; Silvia Maria Franciscato Cozzolino
Abstract

Zinc (Zn) is a mineral with diverse biological functions. It is necessary for 300 enzymes, including Cu, Zn superoxide dismutase (SOD1) that displays important roles in oxidative stress control and in carcinogenesis. Single nucleotide polymorphisms (SNP) in SOD1 gene could lead to increased oxidative stress and cancer development. We aimed at investigating the influence of the A35C (rs 2234694) and G2809A (rs 4998557) SNPs in SOD1 gene on oral and orofaryngeal cancer risk (Study I) and the association between these SNPs, Zn nutritional status and oxidative stress in oral and orofaryngeal cancer patientes (Study II). 169 men with oral and orofaryngeal cancer (cases) and 181 men without the disease (controls) were included in Study I. Genotype frequency distribution for SOD1 A35C was the following: 91% AA, 8% AC and 1% CC (cases). Genotype frequency distribution for SOD1 G2809A was the following: 66% GG, 29% GA and 5% AA (cases) and 62% GG, 34% GA and 4% AA (controls). 29 men with oral and orofaryngeal cancer were included in Study II. Dietary Zn consumption was 10,02 ± 4,8 mg/day. Zn plasma and eritrocyte concentrations were 76,80 ± 23,77µg/dL and 44,26 ± 4,79 µg/g hemoglobin; total SOD activity in the eritrocyte was 1.629,57 ± 675,25 U/g hemoglobin; malondialdehyde (MDA) plasmatic concentration was 1,65 ± 0,58 nmol/dL and ORAC was 2607,89 ± 440,60 µmol TE/L. SOD1 G2809A does not seem to increase oral and orofaryngeal cancer risk. Furthermore oral and orofaryngeal cancer patients seem to present deficiency in Zn nutritional status and increased oxidative stress. (AU)